| Value | ₹1.55 Cr |
|---|---|
| Execution period | Vesting between 2028 and 2030 |
BSE filing, NSE: ARVIND. Summary written from the filing by ALFA Finder's alert engine.
Arvind Ltd: key numbers
- Share price
- ₹512.25
- Market cap
- ₹13,935 Cr
- Revenue (annual)
- ₹9,303 Cr
- Net profit (annual)
- ₹413.9 Cr
- P/E (TTM)
- 30.4×Sector 49.0×
- Promoter holding
- 38.09%-1.44% QoQ
- FII holding
- 15.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arvind Ltd
All →Arvind Earnings Call Transcript: Key Takeaways
Arvind delivered record revenue and EBITDA despite geopolitical disruption. Advanced Materials is becoming a primary engine, diversifying the earnings portfolio away from cyclical textiles.
- Call
- Guides 15% growth
Arvind Other Announcement
Arvind Ltd filed its quarterly Monitoring Agency Report confirming full utilization of Rs.500 crore QIP proceeds with no deviations. The report is a routine SEBI-mandated compliance filing.
Arvind Investor Presentation: Key Takeaways
Q2 FY27 record revenue ₹2919 Cr (+23% YoY), EBITDA ₹331 Cr (+27%), margin 11.4%; PAT pre-exceptional ₹123 Cr (+16%). AMB record revenue ₹805 Cr; Dalco-GFT consolidated.
Arvind Results Update
Arvind's Q2 FY27 revenue hit ₹2,919 Cr and EBITDA ₹331 Cr, growing 23% and 27% YoY. Varanasi garmenting plant commissioned; credit upgraded to AA.
- garmenting facility revenue capacity
- 250 ₹ Cr revenue at full utilization
Arvind Q2 FY27 Results: Net Profit ₹151.6 Cr, Up 42.1% YoY
Arvind Ltd reported revenue from operations of ₹2,919 Cr (+23.1% YoY) and net profit of ₹151.6 Cr (+42.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹151.6 Cr · +42.1% YoY
Arvind Business Update
Arvind inaugurated a greenfield garment plant in Varanasi, its first in Uttar Pradesh. The plant is expected to employ over 1,000 people.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.